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Introduction
Hydrogels are conveniently described as water swollen polymeric materials that retain their mechanical and topological structure in the swollen state. The resultant properties of the hydrogels are dependent on several key parameters including the hydrophilicity of the polymer chains and the degree of cross-linking [1] . Hydrogels may be produced from a wide range of materials (both natural and synthetic) and may be synthesised to offer a wide range of properties that are relevant to drug delivery and medical device design [2] . Key to their use as biomaterials is their high water content as this enhances biocompatibility. At equilibrium, hydrogels may contain from 10 to 98% of water within their polymeric structure [3] although Lydon et al. [4] defined a lower limit of 20% absorbed weight of water. Both the polymer crosslink density and the degree of hydrophilicity of the polymer govern the extent of polymeric swelling. For this reason (and in addition to their flexibility) hydrogels have been used as contact lenses and urethral catheter coatings for several decades [5] [6] [7] .
Hydrogels have been successfully employed for the delivery of bioactive agents [8, 9] . For example, hydrogel-coated catheters have been loaded with antimicrobial agents, their subsequent release being associated with reduced medical device related infection [1, 8] .
Similarly, hydrogels have been used as the platform for the release of anticancer drugs [10] .
Drug release from hydrogels is dependent on the physicochemical properties of the drug and the hydrogel and, in addition, the degree of cross-linking [1] . However, in many cases, the release kinetics are inappropriate for the desired application. For example, when used as medical device coatings, it is necessary that the hydrogels contain sufficient water to aid insertion and to maintain comfort in use, however, drug release from such systems is frequently rapid; thereby limiting their resistance to medical device related infection when implanted for longer durations. To optimise their clinical performance, hydrogels have been designed in which drug release is mediated by external stimuli [11] , e.g. pH [12, 13] , applied magnetic or electrical fields [14, 15] , ultrasound [16] , enzymatic action and/or light [17] .
Hydrogels, primarily based on poly(N-isopropyl acrylamide), have been designed to respond to temperature as an external stimulus. In such systems a change in the phase of the polymer occurs at a defined temperature, referred to as the Lower Critical Solution Temperature (LCST) [18, 19] . Below the LCST, the hydrophilic nature of this polymer facilitates water uptake whereas above the LCST, hydrophobic interactions between the polymer chains result in a collapse of the three-dimensional hydrogel structure and the resultant "responsive" release of drug. Several biological applications for this polymer have been cited including, cell grafting [18] , gene delivery [20] and drug delivery [21, 22] .
The compromised mechanical properties of hydrogels often limit the scope of their applications within medicine [23] . For example, the poor mechanical properties (low ultimate tensile strength, low Young's modulus) limit their use to coatings of medical devices, however, despite this, problems in use, e.g. delamination, fracture upon the application of normal stresses, may occur. The mechanical properties of hydrogels may be improved by copolymerisation [19] , improving crosslink density [1, 24] and using composites, however, whilst incremental improvements have been reported, these strategies are associated with associated disadvantages including modification of the equilibrium water content and adverse modification of drug release profiles. P(NIPAA) hydrogels have been previously reported to possess poor mechanical properties, which have in turn limited their thermoresponsive properties and their potential clinical applications [19, 25] . For example, copolymerisation of NIPAA with acrylate monomers has been reported to enhance the mechanical properties but adversely affect the thermoresponsive properties [19] . Enhancing the crosslink density of p(NIPAA) hydrogels decreases the temperature dependent volume change of the polymer, which in turn affect water uptake and the degree of thermoresponsive behaviour. Therefore, strategies are needed to address this deficiency to ensure that hydrogels are developed that offer optimal drug release, equilibrium water content and mechanical properties.
Within this landscape, this study presents a novel strategy to address this deficiency in which the mechanical properties of thermoresponsive hydrogels may be engineered by the formation of a semi-interpenetrating polymer network (s-IPN) with poly(ε-caprolactone) without the attendant loss of thermoresponsive drug release. It is suggested that the approach presented in this study would be of considerable benefit for drug delivery systems/bioactive devices in which stimulus-responsive release is required from mechanically robust platforms, e.g. medical implants. In particular, it is proposed that these systems may be employed as bioactive biomaterials for use as endotracheal tubes, designed to reduce mortality associated with ventilator associated pneumonia [26] . In particular drug loading of these systems may be performed by nebulisation of solutions of antimicrobial agents at temperatures below the lower critical solution temperature whereas, release, facilitated by mechanical changes to the network, will occur at temperatures above the lower critical solution temperature. The thermal stimulus may be achieved by controlling the temperature of inspired air. This is the first report of a strategy in which thermoresponsive polymer platforms based on p(NIPAA) offering suitable mechanical properties have been designed as endotracheal tube biomaterials.
Materials and Methods

Materials
All chemicals were used as received, requiring no further purification. England and were of AnalaR or equivalent grade.
Materials Synthesis
Poly(HEMA) was prepared by free radical polymerisation, as previously described by the authors [1, 27, 28] . Briefly, the required masses of monomer, initiator (AIBN 1% w/w), metronidazole (1% w/w, as a model drug) and crosslinker (EGDMA, 1% w/w) were mixed by stirring, then injected between two glass plates separated by silicone tubing spacer and release liner and heated at 90°C for one hour. Preparation of poly(NIPAA) and copolymers of NIPAA and HEMA was similarly performed by free radical polymerisation by mixing the required masses of NIPAA (and when required HEMA), EGDMA (1% w/w), AIBN (1% w/w) and metronidazole (1% w/w) prior to polymerisation as described above. Finally, the preparation of the semi-IPNs was performed according to a modification of the method described by Jones et al. [29] . In this poly(ε-caprolactone) ( 
Mechanical analysis
Tensile analysis of hydrated polymer samples was performed using a Stable Micro Systems TA-XT2 Texture Analyser (Goldaming, Surrey, UK) interfaced with a personal computer.
Initially the polymer samples were hydrated to equilibrium in phosphate buffered saline at pH7 and 20 ± 1 o C. Rectangular samples were cut from the swollen s-IPNs to dimensions of 5cm by 1cm using a razor blade and accurately measured using digital Vernier callipers.
Each sample strip was examined to ensure there were no jagged edges, before excess The swelling ratio (SR) was calculated using the equation below:
Determination of the swelling ratio
Where:
W wet and W dry refer to the weights of the sample when wet and dry (initial weight).
Examination of the Thermal Properties of Selected Materials using Differential
Scanning Calorimetry
The thermal properties of selected s-IPNs and their parent hydrogels were examined using differential scanning calorimetry. In this, samples were placed in pans and hermetically sealed with a pinhole lid. Thermal analysis was performed using a TA Instruments MTDSC 2920 (Leatherhead, Surrey), following calibration with Indium. A heating rate of 2 o C min -1 was applied over a temperature range of 20 to 180 o C. In all cases at least quadruplicate measurements of the relationship between heat flow and temperature were determined.
Confocal laser-scanning microscopy (CLSM)
The 
Metronidazole release
Samples of the drug loaded s-IPNs and parent hydrogels (10 x 10mm) were placed into a M c Cartney bottle containing 30ml buffer solution of the required pH and placed into a shaking water bath at either 20 o C or 37 o C and 60 shakes min -1 . Sink conditions were maintained under these conditions. At specified time points, the polymer samples were transferred to another M c Cartney bottle containing 10ml buffer solution while the original sample medium was analysed at 320nm using UV spectrophotometry. The mass of metronidazole in the samples of dissolution media was calculated by reference to a freshly prepared calibration curve prepared in the buffer system (r > 0.99).
Statistical Analysis
For tensile analysis, the effect of hydrogel composition and PCL concentration on the ultimate tensile strength, Young's modulus, percentage elongation and thermal properties were statistically evaluated using a two-way Analysis of Variance (ANOVA). A two-way ANOVA was used to statistically analyse the effects of film composition and temperature on the swelling ratio. Similarly, for the drug release experiments, a two-way repeated measures ANOVA was used to statistically analyse the effects of film composition and temperature on drug release. Post-hoc comparisons of the means of individual results were performed using the Neuman-Keuls test and in all cases p<0.05 denoted significance [30] .
Results
The mechanical properties of the various platforms under investigation are presented in 
Discussion
As a result of their limited mechanical properties, the clinical use of hydrogels has been restricted to certain (defined) applications e.g. contact lenses, soft tissue implants, constructs for tissue engineering and coatings for medical devices [8, 23] . In addition to their use as medical implants/devices, hydrogels have found extensive use as drug delivery systems in which drug release may be diffusion controlled or facilitated by an external stimulus, e.g. pH, temperature [32] [33] [34] . Whilst other polymeric candidates have been examined as platforms for thermoresponsive drug delivery, e.g. poloxamers [35, 36] , the majority of thermoresponsive drug delivery platforms have involved poly(NIPAA) or copolymers of this monomer with other acrylate monomers [37] [38] [39] [40] [41] . Although the ability to poly(NIPAA)-based polymers to offer stimuli sensitive release has been recognised, one of the main limitations associated with the use of these systems as bioactive implants is their sub-optimal mechanical properties [23, 42] . To enhance their mechanical properties (and hence augment their clinical applications), copolymerisation with other monomers, e.g.
acrylic acid, methacrylic acid and methacrylic acid esters or the addition of cross-linkers have been reported [19, 43, 44] . However, there are limitations with these approaches including, reductions in the equilibrium water content and deleterious effects on the thermoresponsive behaviour. Therefore, there is a pharmaceutical need to develop platforms that offer both thermoresponsive behaviour and whose mechanical properties are robust and may be engineered to meet specific clinical demands. Uniquely, this study reports a platform technology that addresses these issues, thereby enhancing the scope of applications for which p(NIPAA) based polymers may be used. This is the first report of the use of thermoresponsive materials designed for use as bioactive endotracheal tubes for the prevention of ventilator associated pneumonia.
The platforms described in this study were prepared by dispersion of molten PCL within the liquid monomer/crosslinker mixture, followed by free radical polymerisation. In a previous study, the authors confirmed that when polymerised in this manner, HEMA and NIPAA form a copolymer [19] . The composition of the hydrogel networks in this study was shown to affect the physicochemical performance of the networks. Examination of the thermal properties of the PCL-containing s-IPNs under examination revealed a melt endotherm (at circa 59 o C), which was statistically similar to the melt temperature of PCL [45, 46] , confirming the existence of PCL as a disperse phase within the hydrogel matrix. In addition, two thermal (glass) transitions were observed that may be accredited to p(NIPAA) (142.04 ± 2.02°C) and p(HEMA-co-NIPAA) (130.05 ± 1.83°C) [19] , the magnitudes of which were unaffected by the presence of PCL. The presence of PCL as a disperse phase within the hydrogel platforms was further confirmed using confocal laser scanning microscopy, in conjunction with the use of dyes that selectively stained the hydrophilic (acridine orange) and hydrophobic areas (rhodamine B) of the platforms. As may be observed from figure two the dyes allowed visualisation of these discrete domains, providing further evidence of the disperse nature of PCL within the hydrogel. Interestingly this is one of the few reports that have involved the use of confocal laser scanning microscopy (with two stain specific dyes) to visualise the physical structure of polymer blends.
Typically, the mechanical properties of poly(HEMA) networks exceeded those of the (HEMA:
NIPAA) copolymer and poly(NIPAA), the properties of poly(NIPAA) being unsuitable for clinical application as an implant or as a medical device biomaterial, where the ability to insert and removal the material is important. Despite the incorporation of a crosslinker (EGDMA), the inappropriate mechanical properties of poly(NIPAA) systems suggested that the number and/or strength of interchain interactions between adjacent poly(NIPAA) chains were lower than those between adjacent chains of poly(NIPAA-co-HEMA) and poly(NIPAA).
The lower Young's modulus and higher % elongation at break illustrates the greater ability of poly(NIPAA) and the copolymer to undergo plastic deformation, highlighting the lower elasticity of these systems. Accordingly in situations where the maintenance of the shape of the drug delivery system is important, e.g. as an implant/insert, hydrogels based on p(NIPAA) would be unsuitable. Incorporation of PCL (in a concentration-dependent fashion)
within the hydrogel matrix significantly enhanced the elastic properties of the various networks, these observations being accredited to the presence of PCL as a disperse, solid phase acting as a filler [47] . Of particular interest are the dramatic enhancements of the ultimate tensile strength and Young's modulus of p(NIPAA) hydrogels in the presence of 10 or 20% w/w PCL, properties that would be suitable for use for applications in which the mechanical properties are essential to the use of the product. In addition, the increase in the ultimate tensile strength and Young's modulus of these materials was not associated with a compromised percentage elongation at break. It is proposed that that materials described in this study would offer particular promise as endotracheal tube biomaterials in which drug loading may be performed by nebulisation of an antimicrobial solution at temperatures below the lower critical solution temperature and drug release may be subsequently initiated by the inspiration of warm air at temperatures exceeding the lower critical solution temperature. To evaluate the mechanical properties of the materials it is appropriate to compare the said properties to those of endotracheal polyvinyl chloride (PVC). In a previous publication [48] , the physicochemical properties of endotracheal tube PVC both containing and devoid of drug were characterised. Typically the ultimate tensile strength, % elongation at break and Young's modulus of PVC were 2.89±0.00 MPa, 285.93±10.28 and 1.12± 0.05MPa, respectively, which, following incorporation of drug (1%, akin to this study) were modified to 1.28±0.00MPa, 114.71±5.28 and 1.15±0.08MPa, respectively. The mechanical properties of the sIPNs described in this study were comparable to endotracheal tube PVC and indeed, in some instances the resistance of the sIPNs to fracture was greater than that of PVC. With the exception of certain drug containing sIPNs (50:50 HEMA:NIPAA containing 1, 5 and 10% PCL), the elongation at break of the sIPNs was generally lower than that of PVC, however, as patients who use these medical devices are immobile, the reduction in magnitude of this parameter would not cause a concern clinically. The elasticity of the s-IPN would be sufficient to resist deformation in use and to facilitate insertion into the trachea without damaging the respiratory tract. Furthermore, the ultimate tensile strength of these s-IPNs are sufficient to prevent fracture during insertion and in situ. Accordingly, it is suggested that the mechanical properties of the s-IPNs described in this study would be sufficient to allow their application as endotracheal tube biomaterials in their own right.
In this study the equilibrium swelling ratios of the networks were examined as functions of respectively. Accordingly, the equilibrium-swelling ratios reflect the swelling below and above the lower critical solution temperature. The temperature independent equilibrium swelling ratios of poly(HEMA) and PCL containing poly(HEMA) confirm the non-thermally responsive properties of these systems. The presence of PCL decreased the equilibriumswelling ratio of systems composed of poly(NIPAA) and poly(NIPAA-co-HEMA), however the most dramatic effect on this parameter was associated with the poly(NIPAA)/PCL (20%w/w) s-IPN. The significance of these observations is two-fold. Firstly, where drug loading is facilitated by immersion of the xerogel into a saturated drug solution, materials that exhibit the greatest equilibrium-swelling ratio will also exhibit the greatest drug loading. Secondly, the polymeric systems that exhibit the greatest reduction in equilibrium swelling ratio would be expected to offer thermoresponsive drug release. Again of great interest to the aim of this study is the pronounced thermoresponsive properties of poly(NIPAA) platforms containing PCL (10 or 20% w/w). The incorporation of PCL significantly lowered the thermoresponsive response however the magnitude of this reduction was small. Typically there was a ten-fold reduction in the volume of these systems below and above the LCST), even in the presence of PCL. Accordingly, in addition to the improved mechanical properties of these systems resultant from the inclusion of PCL, maintenance of pronounced thermoresponsive properties was observed.
Examination of the drug release properties of the various polymer platforms under investigation revealed interesting observations regarding the effects of temperature induced volume changes on this parameter. As expected, PCL containing poly(HEMA) s-IPNs did not exhibit thermoresponsive drug release. However, whilst not thermoresponsive, the release of drug from these systems was controlled and prolonged, with typically circa 70% of the drug payload being released over a 10 hour period. Typically the release of water soluble drugs (e.g. metronidazole) from p(HEMA) is rapid and uncontrolled [1] . Accordingly, these systems, whilst not applicable for this chosen application, may offer opportunities for other medical devices, e.g. intravaginal drug-containing implants. PCL containing poly(NIPAA) s-IPNs exhibited pronounced thermoresponsive release of metronidazole. Interestingly, PCL containing poly(HEMA-co-NIPAA) platforms, despite illustrating temperature-dependent changes in volume, did not exhibit thermoresponsive release of metronidazole, illustrated by statistically similar t 10% , t 30% and t 50% values. Following application of the generalised release model [49] , the release exponents for all PCL containing poly(HEMA-co-NIPAA) platforms were circa 0.5, at each temperature, inferring diffusion (not thermoresponsive) drug release occurred in these systems. It may be therefore inferred that the reduction in volume of these platforms was insufficient to release the drug in a pulsatile fashion or alternatively, the temperature induced rheological (sol-gel) changes occurred prior to the commencement of drug transport. As a result, despite the mechanical improvements offered by the incorporation of PCL within the hydrogel copolymers, these systems do not offer thermoresponsive functionality thereby negating their use as thermoresponsive drug delivery implants. It is important to note the thermoresponsive behaviour of the PCL containing poly(NIPAA) platforms. In this the entire drug payload was released within 1h, despite the enhancement of the structure due to the presence of the dispersed hydrophobic phase.
As defined previously the systems described in this manuscript are designed for use as bioactive endotracheal tubes, their mechanical properties being sufficient to enable their use as the sole constituent of the endotracheal tube (i.e. no coating technologies are required). Ventilator associated pneumonia is frequently associated with the use of endotracheal tubes and then has been itself shown to be due to biofilm on the luminal surface of the endotracheal tube [26] . Strategies for the prevention/treatment of ventilatorassociated pneumonia are therefore targeted at the removal of the microbial biofilm. Whilst in the biofilm, the resistance of microorganisms to antimicrobial agents is markedly increased (up to 1000 fold increase) [50] . Associated with this problem is the inability to achieve sufficiently high concentrations of antimicrobial agent at the luminal surface of the device. Therefore alternative strategies have been developed to address these issues including the use of bioactive endotracheal tubes [51, 52] and the direct nebulization of antimicrobial surfaces across the luminal surfaces of the device and into the lungs [53] .
Typically there is a limited volume of fluid at the luminal surface, therefore presenting a thermodynamic resistance to drug diffusion from the bioactive device. The strategy described in this manuscript has successfully addressed this concern; the associated volume change due to changes in the environmental temperature effectively mechanically driving the drug solution from the polymeric network. Akin to traditional strategies for the treatment of infection, a pulsed released of drug offers is preferred to achieve the highest concentration at the site of action and hence achieve the greatest kill kinetics. Therefore, the observed pulsed release in which the drug load was effectively released over a short period is optimal for the prevention/treatment of ventilator-associated pneumonia. Key to the function of these systems within the clinical environment is the control of temperature within the environment of the endotracheal tube. This may be readily controlled in a number of ways. Firstly, loading of the drug may be achieved by nebulization of an antimicrobial solution at a temperature below the lower critical solution temperature of the polymer platform; the swelling of the polymer will enable an effective uptake of the solution within the network. Maintenance of this temperature within the respiratory tract may be performed by controlling the temperature of the inspired air. Under which conditions drug release will not occur due to the thermodynamic restraints imposed by the system due to the limited volume of fluid adjacent to the luminal surface of the device. When required the temperature of the inspired air may be elevated temporarily to ensure that the temperature of the air surrounding the device exceeds the lower critical solution temperature of the polymer network. Under these conditions, drug release will be facilitated by a change in the volume of the polymer network, a process that is not dependent on diffusion. This ability to offer pulsatile drug release that is modulated by the temperature of the inspired air is suggested to be particular applicable for the improved treatment/prevention of ventilator associated pneumonia.
Conclusions
This study describes the design of thermoresponsive semi-interpenetrating polymer networks based on crosslinked poly(NIPAA) or poly(NIPAA-co-HEMA) hydrogels containing poly(ε-caprolactone) that are designed for use as endotracheal tube biomaterials. The lower critical solution temperature of the co-polymer and poly(NIPAA) matrices were circa 34 o C and 32 o C, respectively, confirming the thermoresponsive behaviour of these systems at physiological temperatures. PCL was physically dispersed within the hydrogel matrices as confirmed using confocal laser scanning microscopy and differential scanning calorimetry.
The elastic properties of poly(NIPAA) hydrogels were lower than comparator hydrogels release may then be activated by increasing the temperature of the inspired air above the lower critical solution temperature, the rapid release of a high concentration of drug offering the optimum opportunity to resolve the microbial biofilm on the luminal surface of the endotracheal tube. It is suggested that the biomaterials described in this study offer a novel strategy for the prevention/treatment of ventilator-associated pneumonia.
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